#270 Burning Evidence for Fosfomycin in Cystitis
CLINICAL QUESTION
What is the efficacy of fosfomycin for uncomplicated cystitis in non-pregnant women?
BOTTOM LINE
At best, single dose fosfomycin has similar efficacy to other antibiotics for uncomplicated cystitis. However, the best quality, publicly funded trial showed it was not as efficacious as nitrofurantoin, with 58% of cases clinically resolving at 28 days compared to 70% for nitrofurantoin.
Reading Tools for Practice Article can earn you MainPro+ Credits
Join NowAlready a CFPCLearn Member? Log in
EVIDENCE
Most recent systematic review1, 11 randomized controlled trials (RCTs), 1976 women, fosfomycin versus other antibiotics (examples norfloxacin, trimethoprim/sulfamethoxazole, nitrofurantoin) showed:
- Clinical cure or improvement (non-complete symptom resolution): no difference.
- Limitations: unreliable results (combined cure and failure rates together in the same analysis), most studies over 20 years old and industry sponsored.
- Focusing on 4 heaviest weighted RCTs (make up >85% of outcomes in systematic review):
- Most recent, highest quality, publicly funded, open-label RCT2of fosfomycin versus nitrofurantoin in 494 women. At 28 days:
- Clinical resolution: 58% versus 70% nitrofurantoin, number needed to harm=8.
- Adverse events: no difference.
- Manufacturer-sponsored, double-blind RCT3 of fosfomycin versus nitrofurantoin in 231 women:
- Cured or improved: no difference at Day 4, 9, or 42.
- Stopped due to adverse events: 6% versus 0 nitrofurantoin (mainly gastrointestinal).
- Limitations: unable to track all patient outcomes, study is 27 years old, not all randomized patients included in analysis.
- “Worst-case” analysis accounting for missing data resulted in statistically fewer patients improving by Day 9: 84% versus 95% nitrofurantoin.
- Manufacturer-sponsored double-blind RCT4 of fosfomycin versus nitrofurantoin in 521 women:
- Cured: no difference up to 6 weeks after treatment.
- Stopped due to adverse events: 2.6% versus 6.3% nitrofurantoin (not statistically different).
- Limitations: not all randomized patients included in analysis, single author, study is 21 years old.
- Second heaviest weighted RCT5: primary outcome was rectal cultures, not relevant.
- Most recent, highest quality, publicly funded, open-label RCT2of fosfomycin versus nitrofurantoin in 494 women. At 28 days:
- Guidelines recommend nitrofurantoin, fosfomycin, or trimethoprim/sulfamethoxazole (if low risk of resistance) as empiric first-line treatment for uncomplicated cystitis in women.6,7
- Fosfomycin is a single-dose, orange-flavoured, powder sachet for dissolution in cold water.8
- Pricing: fosfomycin ~$30, nitrofurantoin ~$20 (5 days).9
- No renal adjustments required for fosfomycin.8
Latest Tools for Practice
#378 Tony Romo-sozumab: Winning touchdown in osteoporosis or interception for the loss?
What is the efficacy and safety of romosozumab in postmenopausal women with osteoporosis?
#377 How to slow the flow IV: Combined oral contraceptives
In premenopausal heavy menstrual bleeding due to benign etiology, do combined oral contraceptives (COC) improve patient outcomes?
#376 Testosterone supplementation for cis-gender men: Let’s (andro-)pause for a moment (Update)
What are the benefits and harms of testosterone supplementation in healthy cis-gender men or those with age-related low testosterone?
fosfomycin single dose not as effective